UltraRIPA kit for Lipid Raft (1 kit)

Product#: FNK-F015
$179.20
Availability:
Ships in 24 hours

UltraRIPA kit for Lipid Raft


Cat. No. FNK-F015

Size 1 kit
NIH NSN# 664000N172813

Kit components


A buffer (RIPA buffer) 100 mL
B buffer 10 mL
Store at 4oC, Product shelf life  1 year 

Product ID and Size
 
Cat No. Size Link
FNK-F015 1 Kit Mammalian Cell Culture, Animal Cell Culture-Classic Media, Diagnocine
FNK-F015-Trial 1 Kit Mammalian Cell Culture, Animal Cell Culture-Classic Media, Diagnocine


Description

Next-Generation RIPA Buffer for High Efficient Membrane Protein Extraction

RIPA buffer is one of the most useful buffers for protein extraction. RIPA buffer maintains most native structures of proteins and the extracted proteins can be applied to various applications. However, RIPA buffer is not sufficient to extract membrane proteins and membrane-associated proteins concentrated in lipid raft. 

Lipid raft is a highly specialized microdomain on the lipid bilayer which contains specialized lipids, cholesterol and functional proteins. These lipid rafts are also called “Detergent Resistant Membrane (DRM)”, as lipid raft-enriched proteins are usually insoluble by mild detergent buffers such as 1% Triton X-100 and RIPA buffer. Consequently, it was difficult to analyze functions of lipid raft-enriched proteins extracted with RIPA buffer. 

BioDynamics Laboratory's newly developed product : the UltraRIPA kit, can efficiently and rapidly extract membrane proteins or membrane-associated proteins enriched in lipid rafts with native structure and function. 

UltraRIPA kit includes a totally new buffer not containing protein denaturing detergents, but can extract the DRM which was difficult to extract by conventional RIPA buffer. UltraRIPA kit helps to analyze various biological assays of the proteins in lipid raft.

F015_fig1.png 

Features of UltraRIPA kit

  • Extract membrane / membrane associated proteins enriched in lipid rafts, with native structure and fully retained function.
  • Easy and Simple Procedure : Only a centrifuge is required
  • Only two components: A buffer and B buffer


Overview of Procedure

Kit components

A buffer (RIPA Buffer) : 100 mL 
B buffer : 10 mL

F015_fig2.jpg

Overview of advantages of ULTRARIPA kit

Protein Extraction Buffer

Protein Extraction

Protein Structure

Protein Function

Application

Cytosolic

Membrane

Non-lipid raft

Lipid raft

> 1% SDS buffer

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/batsubatsu.png

https://www.funakoshi.co.jp/domestic/f-img/ds/batsubatsu.png

SDS-PAGE

RIPA buffer

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/batsubatsu.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

Enzymatic assay,
Immunoprecipitation,
SDS-PAGE,etc

ULTRARIPA kit

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

https://www.funakoshi.co.jp/domestic/f-img/ds/marumaru.png

 


Protein extraction efficiency of ULTRARIPA kit

F015_5.png F015_3.png

Extraction of RIPA-insoluble proteins by ULTRARIPA kit

Left : Quantification of extracted total proteins by BCA protein assay. ULTRARIPA kit could constantly extract over 70% of RIPA-insoluble proteins from the mouse brain tissue.

Right : Western blotting of lipid raft markers. Some lipid raft markers among proteins or a ganglioside extracted were dramatically increased in RIPA-insoluble fraction by ULTRARIPA kit.

F015_fig4.jpg

Enzyme activity assay of proteins extracted by ULTRARIPA kit

Left : Lactate Dehydrogenase activity of proteins extracted by using 1% Triton X-100, A and B buffer. Equivalent enzyme activity are obtained when using A and B buffer. 

Right: Total protein phosphatase activity. Protein extracts from RIPA-insoluble fraction of the mouse whole brain by ULTRARIPA® kit B-buffer, RIPA, and 2% SDS buffer were applied to total protein phosphatase assay. Although 2% SDS buffer completely extracted proteins, but it disrupted phosphatases. In contrast, ULTRARIPA® kit showed greatly higher activity of protein phosphatases than 2% SDS and RIPA buffer

Note

  • Both A and B-buffer could not be applied to Bradford protein assay.
  • Please use BCA protein assay if you would like to quantitate protein concentration.
Troubleshooting

Problem

Possible Cause

Solution

Low RIPA-insoluble fraction yield

Less of total protein Use more

starting cells or tissues

Low concentration of

Excess buffer used

proteins Use less buffer

Degradation of proteins

No protease inhibitors added

Add any protease inhibitors to the both buffers before use


Application

F015_6.png 
F015_7.png 
F015_8.png 
F015_9.png 
F015_10.png 

Reference

 

Oncology & Cancer Metastasis Research

These studies utilize the buffer to break down tight cellular structures or isolate membrane-bound signaling complexes to understand how tumors invade healthy tissue or resist chemotherapy:

  • ACSL4 & Melanoma Protective Barriers: Zhao X. et al. (2024) studied how ACSL4-mediated lipid rafts structurally prevent membrane rupture, thereby shielding melanoma cells from immunogenic cell death.

  • Mitophagy in Cancer Cells: Araki K. et al. (2019) isolated mitochondrial fractions to show how a distinct mitochondrial protein ($E2F3d$) drives hypoxia-induced mitophagy.

  • Chemoresistance Spheroid Models: A series of studies by Ohya S., Kajikuri J., and Otsuka R. (2021, 2026) used the non-denaturing qualities of the buffer on 3D tumor spheroids (sarcoma, prostate, and breast cancers) to isolate active ion channels ($K_{Ca}1.1$ and $LRRC8A$) that regulate drug transporter expressions ($MRP3$, $CYP3A4$).

  • Gefitinib Resistance in EGFR Treatment: Ding X. et al. (2019) used it to study membrane-bound epidermal growth factor receptors.

  • Mitochondrial Disruption: Liu D. (2022) looked at reversing multidrug resistance by targeting tightly bound mitochondrial membrane fractions.

  • OSCC Cell Migration: Chan NN. et al. (2023) extracted caveolae-associated proteins ($CAV1$) to study cholesterol-regulated migration in Oral Squamous Cell Carcinoma.

  • Clear Cell Renal Cell Carcinoma: Takai Y. et al. (2025) lysed cell complexes to track the interaction of $Ankrd1$ with $Talin-1$ during cell motility.

  • High-Throughput Biomarker Screening: Hayashi T. et al. (2022) extracted human osteosarcoma-specific surface antigens while keeping their structural epitopes native for phage display screening.


Neurology & Brain Tissue Research

Brain tissue is rich in myelin and complex lipid structures, making standard extraction notoriously difficult. These papers leveraged the kit to isolate functional neuro-proteins:

  • Synapse Formation & Glia: Dewa K. et al. (2024) extracted perisynaptic membrane fractions to prove that neuronal $DSCAM$ regulates the localized anchoring of $GLAST$ in Bergmann glia.

  • Alzheimer’s Disease Amyloid Fibrils: Stern AM. et al. (2023) processed aqueous extracts from human Alzheimer's disease brains to capture abundant, dense $A\beta$ fibrils from ultracentrifugal supernatants.

  • Down Syndrome & Alzheimer’s Lysosomes: Im E. et al. (2023) tracked lysosomal dysfunction caused by $v-ATPase$ inhibition using brain tissue extracts.

  • Motor Coordination: Tan L. et al. (2018) processed striatum tissue to look at neutral sphingomyelinase 2 regulation of lipid raft volume.

  • Epilepsy & Brain Activity: Tahara M. et al. (2023) analyzed brain tissue components in heterozygous $Scn1a$ knockout rat models.


Virology, Immunology & Pathology

Keeping viral spike proteins or delicate immune receptors structurally intact without denaturing them is vital for these studies:

  • SARS-CoV-2 Spike Protein Integrity: Murae M. (2022) and Yamamoto Y. (2022) isolated functional SARS-CoV-2 spike proteins to test how disulfide-bond disruptions (via glutathione or peracetic acid) impair viral functionality.

  • Tick-Borne Encephalitis Virus (TBEV): Yang Q. et al. (2021) isolated membrane structures to determine that $ADAM15$ physically participates in viral replication.

  • Lupus & Arthritis Therapies: Wang R. et al. (2022) extracted delicate apoptotic vesicles to assess how they modulate T-cell receptor signaling pathways.

  • Pemphigoid Autoantibodies: Mai S. et al. (2023) extracted a native autoantigen complex from skin tissue cells, which requires completely non-denaturing conditions to successfully detect autoantibodies.

  • Bacterial Toxin Transcytosis: Linden JR. et al. (2019) isolated caveolae fractions to track Clostridium perfringens epsilon toxin crossing the blood-brain barrier.

  • Anti-Inflammatory NF-κB Signaling: Hayakawa K. et al. (2019) utilized it for downstream evaluation of microRNA-766-3p actions.

  • CD40 Agonist Immunotherapy: Frankish J. et al. (2023) studied cell-surface antigen-presenting complex activations.


Metabolism, Endocrinology & Cardiovascular Disease

  • Lipid Storage in HepG2 Cells: Chean J. et al. (2021) isolated the fatty acid transporter $CD36$ and $CEACAM1-LF$ complexes from liver cell lines.

  • Right Ventricular Heart Failure: Ito S. et al. (2022) evaluated cardiac tissue membrane signaling loops ($C3-CFD-C3aR$).

  • Vascular Smooth Muscle Contraction: Tsurudome N. et al. (2023) tracked the endocytosis pathways of Sphingosylphosphorylcholine.

  • Retinal Vascular Regression: Yokota K. et al. (2024) analyzed neurovascular unit structural stability via platelet-derived growth factors.

  • Female Fertility Regulation: Chen LJ. et al. (2022) mapped the anchoring of $Gm364$ with $MIB2/DLL3/Notch2$ complexes to study AKT activation.

  • Pulmonary Hypertension: Kabwe JC. et al. (2022) evaluated lung tissue signaling shifts induced by a point mutation in $Bmpr2$.

  • Cell Surface Localization & Glucose: Toyoda Y. et al. (2018) extracted multipass transmembrane proteins from HeLa cell surfaces to evaluate $GRP78$ dependence.

  • Diabetic Foot Calluses: Tsuruoka K. et al. (2020) extracted Desmocollin1 tightly bound inside rigid skin corneocytes.

   
  Related Products  
Please, click below each image if you need more info.   

logo_BDL.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X